Literature DB >> 12694965

The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration.

Hany Abdel-Aleem1, José Villar, A Metin Gülmezoglu, Sayed A Mostafa, Alaa A Youssef, Mahmoud Shokry, Bernhard Watzer.   

Abstract

OBJECTIVE: To study pharmacokinetics of prostaglandin E1 analogue, misoprostol in plasma and colostrum after postpartum oral administration. STUDY
DESIGN: Twenty women received 600 microg doses of misoprostol orally after delivery. Plasma levels of the principal metabolite, misoprostol acid, were measured at 2, 10, 20, 30, 40, 50, 60, 90, 120, 180, 240 and 300 min (48 samples). Colostrum was expressed from the breasts to measure misoprostol acid at 60, 120, 180, 240, and 300 min (24 samples). Assay was done using isotope dilution gas chromatography (GC)/negative ion chemical ionisation mass spectrometry (MS).
RESULTS: The plasma concentration of misoprostol acid rose quickly. Two minutes after oral administration its mean level was 91.5 pg/ml, peaked at 20 min (344 pg/ml), then fell steeply by 120 min (27.8 pg/ml) and remained low for the duration of the study. Misoprostol acid in colostrum reached maximum concentration of 20.9 pg/m within 1h after oral administration. It then declined gradually to 17.8 pg/ml at 2h, 2.8 pg/ml at 4h and to <1 pg/ml at 5h. Areas under misoprostol concentration versus time curves up to 5h were 290.1 pgh/ml in the plasma and 51.4 pgh/ml in colostrum, respectively.
CONCLUSION: Misoprostol acid is secreted in colostrum within 1h of oral administration of 600 microg of misoprostol; the pharmacokinetics of misoprostol after oral administration during postpartum is similar to that of other pregnancy periods.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694965     DOI: 10.1016/s0301-2115(02)00355-x

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Abortion after deliberate Arthrotec® addition to food. Mass spectrometric detection of diclofenac, misoprostol acid, and their urinary metabolites.

Authors:  Bernhard Watzer; Klaas J Lusthof; Horst Schweer
Journal:  Int J Legal Med       Date:  2014-12-19       Impact factor: 2.686

Review 2.  Treatment for primary postpartum haemorrhage.

Authors:  Hatem A Mousa; Jennifer Blum; Ghada Abou El Senoun; Haleema Shakur; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2014-02-13

Review 3.  Oral misoprostol for induction of labour.

Authors:  Zarko Alfirevic; Nasreen Aflaifel; Andrew Weeks
Journal:  Cochrane Database Syst Rev       Date:  2014-06-13

4.  Low-dose oral misoprostol for induction of labour.

Authors:  Robbie S Kerr; Nimisha Kumar; Myfanwy J Williams; Anna Cuthbert; Nasreen Aflaifel; David M Haas; Andrew D Weeks
Journal:  Cochrane Database Syst Rev       Date:  2021-06-22

5.  Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357].

Authors:  G Justus Hofmeyr; Sandra Ferreira; V Cheryl Nikodem; Lindeka Mangesi; Mandisa Singata; Zukiswa Jafta; Babalwa Maholwana; Zonke Mlokoti; Gijs Walraven; A Metin Gülmezoglu
Journal:  BMC Pregnancy Childbirth       Date:  2004-08-06       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.